RECORDATI NETHERLANDS B.V.
ItalyAll drugs from this manufacturer
-
It is used for the treatment of advanced renal cancer in adults, when other treatments have not been used or have failed to stop the disease.
Dosage form: capsules, hard gelatin
Active substance Dosage tivozanib - ATC: L01EK03
-
It is used for the treatment of neuroblastoma (a type of cancer that affects nerve cells) in patients at high risk of relapse after other treatments, or in cases of neuroblastoma that has recurred or has not been completely cured by previous therapies. It is indicated for patients from 12 months of age.
Dosage form: solution for infusion, concentrate
Active substance Dosage dinutuximab beta - ATC: L01FX06
-
It is used for the treatment of multicentric Castleman disease (MCD) in adult patients who do not have HIV or human herpesvirus-8 (HHV-8) infections.
Dosage form: powder for concentrate for infusion solution
Active substance Dosage siltuximab - ATC: L04AC11